Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi, +16

JNCI Journal of the National Cancer Institute

Breast OncologyEngineeringPathologyHistologic GradeCancer Biology +18

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

Lance D. Miller, Johanna Smeds, Joshy George, +8

Proceedings of the National Academy of Sciences

P53 StatusBreast OncologyEngineeringPathologyGene Expression Profiling +16

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Yudi Pawitan, Judith Bjöhle, Lukas C. Amler, +17

Breast Cancer Research

Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer

Anna V. Ivshina, Joshy George, O. V. Sen’ko, +12

Cancer Research

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

Stefano Calza, Per Hall, Gert Auer, +9

Breast Cancer Research

Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome

Jonna Frasor, Edmund C. Chang, Barry S. Komm, +7

Cancer Research

Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase

Oddbjørn Straume, Johanna Smeds, Rajiv Kumar, +2

American Journal Of Pathology

Tumor BiologyT PolymorphismVertical Growth PhaseCutaneous BiologyPhotocarcinogenesis +8

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

Chin‐Yo Lin, Anders Ström, Say Li Kong, +9

Breast Cancer Research

Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus)

Rajiv Kumar, Johanna Smeds, Barbro Lundh Rozell, +1

Melanoma Research

A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare

Rajiv Kumar, Johanna Smeds, Petra Berggren, +4

International Journal of Cancer